Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136 USD | -0.73% | -0.73% | -.--% |
Sales 2024 * | 88.37B 7,039B | Sales 2025 * | 90.78B 7,231B | Capitalization | 361B 28,740B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 1,756B | Net income 2025 * | 23.09B 1,839B | EV / Sales 2024 * | 4 x |
Net cash position 2024 * | 7B 557B | Net cash position 2025 * | 21.07B 1,679B | EV / Sales 2025 * | 3.74 x |
P/E ratio 2024 * |
16.7
x | P/E ratio 2025 * |
15.7
x | Employees | - |
Yield 2024 * |
3.22% | Yield 2025 * |
3.36% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
1 week | -0.73% | ||
3 months | -22.29% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 31/12/88 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 31/12/97 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 24/04/19 |
D. Davis
BRD | Director/Board Member | 72 | 18/06/14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 21/10/09 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B | |
-1.22% | 159B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock